Want to join the conversation?
$PPL 2Q15 Call: Across portfolio, over $10Bil in CapEx spending is expected to produce compound annual rate based growth of more than 7% or $5Bil by 2017. For 2015 through 2017, over 80% of that CapEx earns a return within 12 months; & approx. 76% in less than six months. This combination creates very strong foundation for future earnings growth.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.